STRS Ohio’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$200K Sell
14,300
-9,500
-40% -$133K ﹤0.01% 1661
2025
Q1
$324K Hold
23,800
﹤0.01% 1369
2024
Q4
$485K Buy
23,800
+6,400
+37% +$130K ﹤0.01% 1224
2024
Q3
$507K Hold
17,400
﹤0.01% 1256
2024
Q2
$404K Buy
17,400
+4,400
+34% +$102K ﹤0.01% 1342
2024
Q1
$266K Sell
13,000
-800
-6% -$16.4K ﹤0.01% 1477
2023
Q4
$296K Hold
13,800
﹤0.01% 1461
2023
Q3
$284K Hold
13,800
﹤0.01% 1469
2023
Q2
$407K Sell
13,800
-8,100
-37% -$239K ﹤0.01% 1368
2023
Q1
$504K Sell
21,900
-11,800
-35% -$272K ﹤0.01% 1311
2022
Q4
$937K Hold
33,700
﹤0.01% 961
2022
Q3
$1.03M Hold
33,700
﹤0.01% 879
2022
Q2
$991K Buy
33,700
+2,800
+9% +$82.3K ﹤0.01% 927
2022
Q1
$994K Hold
30,900
﹤0.01% 1042
2021
Q4
$1.38M Hold
30,900
﹤0.01% 934
2021
Q3
$1.56M Sell
30,900
-300
-1% -$15.1K 0.01% 836
2021
Q2
$2.45M Buy
31,200
+4,600
+17% +$361K 0.01% 669
2021
Q1
$1.52M Buy
26,600
+6,800
+34% +$388K 0.01% 878
2020
Q4
$1.66M Buy
19,800
+7,900
+66% +$662K 0.01% 786
2020
Q3
$426K Hold
11,900
﹤0.01% 1421
2020
Q2
$287K Sell
11,900
-20,900
-64% -$504K ﹤0.01% 1547
2020
Q1
$574K Hold
32,800
﹤0.01% 1035
2019
Q4
$571K Hold
32,800
﹤0.01% 1380
2019
Q3
$502K Hold
32,800
﹤0.01% 1278
2019
Q2
$680K Buy
+32,800
New +$680K ﹤0.01% 1035
2018
Q2
Sell
-4,600
Closed -$90K 2132
2018
Q1
$90K Buy
+4,600
New +$90K ﹤0.01% 1639